Monoclonal Antibody Treatment Mobile Outpatient Services

The State of Nevada Department of Administration Purchasing Division, on behalf of the Department of Health and Human Services, Division of Public and Behavioral Health, has issued a Request for Qualifications (RFQ) for qualified vendors to provide monoclonal antibody treatment mobile or fixed outpatient services for the treatment of SARS-CoV-2/COVID-19 across the state. The selected contractors will be required to provide staffing, equipment, supplies, and amenities for the treatment services. Proposals will be evaluated based on mandatory minimum requirements, vendor background and staff, response to the scope of work, and cost, with a minimum score of 12 out of 20 points required for award. The State intends to award multiple contracts resulting from this rolling solicitation, with proposals accepted and reviewed on an ongoing basis until the final deadline of December 31, 2021. The resulting contracts are expected to be for a term of four years, subject to Board of Examiners approval.

The State encourages participation from small businesses, minority-owned, veteran-owned, and women-owned enterprises. No incumbent vendors or budget ranges are specified in the provided materials. The contract will likely involve federal funding, as the vendor must comply with various federal laws, regulations, and certifications, including provisions related to lobbying, environmental protection, and non-discrimination.